Vaccines and Immunity: Is Omicron the last threat?
Wednesday, March 2, 2022
SARS-CoV-2 variations are keeping us on our toes in our fight against COVID-19. WHO announced in late November that there is a Variant of Concern (VOC), Omicron, with 32 mutations in the spike protein. This is about double that of the Delta strain, which is currently dominating COVID-19 infections around the world. This new VOC is expected to be more transmissible and infectious than the Delta strain. How quickly and widely would Omicron spread? Would it dominate the other variants? Would this new variant reduce vaccine effectiveness? In this webinar, we will discuss the recent developments in our fight against COVID-19 and changes in vaccination programmes to effectively combat Omicron.
Chair and Moderator: Prof Wang Linfa - Professor, Programme in Emerging Infectious Diseases, Duke-NUS Medical School, & Executive Director, PREPARE, Singapore
Speaker and Panellist: Prof David Heymann - Professor, Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
ASEAN Dx Initiative Co-chairs: Dr Jaime Montoya - Executive Director, Council for Health Research and Development, Philippines Dr Sidney Yee – Founding Chief Executive Officer, Diagnostics Development Hub & Adjunct Associate Professor, Centre of Regulatory Excellence, Duke-NUS Medical School, Singapore